Use of the Wearable Cardioverter-Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry.
El-Battrawy I, Koepsel K, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Gotzmann M, Klein N, Kuntz T, Shin DI, Lapp H, Rosenkaimer S, Abumayyaleh M, Hamdani N, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Akin I, Aweimer A, Beiert T.
El-Battrawy I, et al. Among authors: kowitz j.
J Am Heart Assoc. 2023 Sep 19;12(18):e030615. doi: 10.1161/JAHA.123.030615. Epub 2023 Sep 8.
J Am Heart Assoc. 2023.
PMID: 37681569
Free PMC article.